Department of Ophthalmology & Visual Sciences, St Paul's Hospital, Ophthalmology
Vancouver, British Columbia, V6Z 1Y6, Canada
Location contact
Bryon McKay, MD, PhD
CONTACT
Bryon McKay, MD, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06536569
This study is a Single center, prospective, observational, multi surgeon randomized controlled trial. Subjects will be assessed pre-operatively, operatively and at 1 month postoperatively. Clinical evaluations will include measurement of visual acuity and optical coherence tomography (OCT).
Trial opening soon.
Get Notified19 year and older
All sexes
Interventional
Phase 4
Vancouver, British Columbia, V6Z 1Y6, Canada
Bryon McKay, MD, PhD
CONTACT
Bryon McKay, MD, PhD
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
25g Grieshaber Sharkskin ILM Forceps with Reflex Handle
25g Grieshaber Standard ILM Forceps
Time frame: Surgery (Operative Visit)
Evaluated by recorded video
Time frame: Surgery (Operative Visit)
Evaluated by recorded video
Time frame: Surgery (Operative Visit)
Start to completion of peel
Time frame: Surgery (Operative Visit)
Evaluated by recorded video
Time frame: 1 Month Postoperatively
Contact information is provided by the study sponsor or research team.
University of British Columbia
Other
A Comparison of the Efficacy of 25g Grieshaber Sharkskin ILM Forceps With Reflex Handle vs Standard 25g Grieshaber ILM Forceps for Internal Limiting Membrane Peeling
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03713268
Cardiovascular Diseases, Cataract
Durham, North Carolina, United States
View Trial DetailsNCT04723160
Arterial Occlusive Diseases, Cardiovascular Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT05171621
Epiretinal Membrane, Eye Diseases
Cardiff, United Kingdom
View Trial DetailsNCT05086588
Epiretinal Membrane, Eye Diseases
Istanbul, Turkey (Türkiye)
View Trial Details